Intrahepatic Cholestasis in Sickle Cell Disease: A Case Report

Intrahepatic cholestasis (SCIC) is an uncommon but potentially fatal complication of sickle cell disease (SCD), with a high death rate, observed mainly in patients with homozygous sickle cell anemia. Herein, we describe a case of severe SCIC treated successfully with aggressive manual exchange trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunetta, Denise Menezes, Silva-Pinto, Ana Cristina, Favarin de Macedo, Maria do Carmo, Bassi, Sarah Cristina, Piccolo Feliciano, Joao Victor, Ribeiro, Fernanda Borges, Prado, Benedito de Pina Almeida, De Santis, Gil Cunha, Angulo, Ivan de Lucena, Covas, Dimas Tadeu
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065851/
https://www.ncbi.nlm.nih.gov/pubmed/21490769
http://dx.doi.org/10.1155/2011/975731
Descripción
Sumario:Intrahepatic cholestasis (SCIC) is an uncommon but potentially fatal complication of sickle cell disease (SCD), with a high death rate, observed mainly in patients with homozygous sickle cell anemia. Herein, we describe a case of severe SCIC treated successfully with aggressive manual exchange transfusion (ET). The patient was admitted with enlarged liver and signs of hepatic failure, such as hyperbilirubinemia and coagulopathy. There was no evidence of viral hepatitis or biliary obstruction. We performed several sessions of ET in order to reduce the percentage of HbS to levels inferior to 30%, which was successfully accomplished. The patient had a complete recovery of hepatic function. This case has shown that ET is an effective treatment of SCIC and should be introduced early on the onset of this severe complication.

Ejemplares similares